The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The role of Ki-67 proliferation index vis-à-vis Oncotype DX.
S. Sahebjam
No relevant relationships to disclose
R. Aloyz
No relevant relationships to disclose
D. Pilavdzic
No relevant relationships to disclose
M. Brisson
No relevant relationships to disclose
C. Ferrario
No relevant relationships to disclose
N. Bouganim
No relevant relationships to disclose
V. Cohen
No relevant relationships to disclose
W. H. Miller
No relevant relationships to disclose
L. C. Panasci
No relevant relationships to disclose